Showing results (21-30 of 320) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapyV Gandhi, E Estey, M Du, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Inhibition of fludarabine metabolism by arabinosylcytosine during therapyA Kemena, V Gandhi, D S Shewach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequencesV Gandhi, P Huang, A J Chapman, et al.
Cancer Research|October 1, 1996
Excision of 2',2'-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNAV Gandhi, J Legha, F Chen, et al.
Leukemia|September 1, 1987
Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemiaL Danhauser, W Plunkett, J Liliemark, et al.
Seminars in Oncology|August 1, 1995
Gemcitabine: metabolism, mechanisms of action, and self-potentiationW Plunkett, P Huang, Y Z Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemiaV Gandhi, E Estey, M Du, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemiaV Gandhi, W Plunkett, H Kantarjian, et al.
Leukemia & Lymphoma|March 1, 1993
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemiaE Estey, W Plunkett, V Gandhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulationS R Patel, V Gandhi, J Jenkins, et al.
Pageof 32